BioCentury
ARTICLE | Distillery Therapeutics

KLRG1 inhibition to treat breast cancer, colorectal cancer and melanoma

Claire Quang
April 10, 2019 1:52 PM UTC

INDICATION: Breast cancer; colorectal cancer; melanoma...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Abcuro Inc.

Harvard Medical School